APCER Life Sciences

Team APCER is at REMS Industry Consortium's RIC Annual Meeting 2025 in Arlington, VA to advance patient safety & risk mitigation. #REMS #PatientSafety #APCERLifeSciences #RIC2025 #riskmanagement #RICAnnualMeeting2025

Transform your regulatory journey with APCER's streamlined solutions. Fast-track approvals, predict challenges and lead the market. EXPLORE MORE: https://rb.gy/altfbi #RegulatoryExcellence #RegulatoryAffairs #APCERLifeSciences

📊 Case Study Alert! How we guided a US biopharma company through FDA Type B meetings for their oncology drug development program. See how expert regulatory support drives success. 🔬 READ MORE: https://shorturl.at/POevI #FDAMeetings #TypeB #Oncology #regulatory #regulatoryaffairs #medicalwriting #APCERLifeSciences

🔍 Whitepaper Alert! Demystifying Named Patient Programmes (NPP) Globally In today's rapidly evolving pharmaceutical landscape, understanding how to provide early access to life-saving medications is crucial. Our comprehensive whitepaper breaks down the complexities of Named Patient Programmes across major markets. 📊 Key Insights Include: • Clear distinctions between NPP, Expanded Access, and Compassionate Use • Country-specific regulatory frameworks • Implementation strategies for healthcare professionals • Critical pathways for early medication access 🏥 At APCER Life Sciences, our regulatory experts help navigate these complex pathways to ensure timely access to unapproved medicines while maintaining patient safety. DOWNLOAD NOW: https://shorturl.at/YRszP #Healthcare #Pharmaceutical #RegulatoryAffairs #PatientCare #MedicalInnovation #APCERLifeSciences

Ensure seamless compliance with APCER Life Sciences! 🌍 100% compliance rate for submissions and publishing, 95% submissions ahead of time. Your trusted partner in post-approval management. Explore More: https://shorturl.at/haqg9 #APCERLifeSciences #RegulatoryCompliance #PostApprovalLifecycleManagement

Highlights from Day 2 at DIA Europe 2025!   What an incredible second day at DIA Europe 2025 in Basel, Switzerland!   A standout moment from the event was the engaging session led by PURAV THAKKAR, our Vice-President of Pharmacovigilance. He delivered a compelling presentation on “Benefits of Early Risk Profiling for CAR T-Cell Therapies” during the Innovation in Pharmacovigilance CAR-T, Gene Therapies and New Modalities session.   As we wrap up another fantastic day, remember to visit Booth #F5! Our team of experts is ready to discuss customized solutions for drug safety and regulatory compliance.   #DIAEurope2025 #DIA #Pharmacovigilance #CARTherapies #DrugSafety #RegulatoryCompliance #APCERLifeSciences

Proud to join CodeX HL7 FHIR Accelerator as Developer/Implementer Member! We at APCER Life Sciences are honored to join CodeX as a Developer/Implementer Member on the Risk Evaluation and Mitigation Strategies (REMS) use case team. We're excited to contribute our pharmacovigilance and regulatory compliance expertise to advance FHIR-enabled REMS data exchange solutions that improve patient safety and streamline healthcare workflows. Looking forward to collaborating with the CodeX community to transform healthcare interoperability! #HealthcareInnovation #FHIR #PatientSafety

🌟Meet Team APCER at REMS Industry Consortium's RIC Annual Meeting 2025! This event promises to be action-packed, connecting #REMS professionals and fostering collaboration. Together, we aim to advance patient safety, enhance access, and share best practices in risk management. #REMS #PatientSafety #APCERLifeSciences #RIC2025 #RICAnnualMeeting2025 #riskmanagement

Colors, games, music, and smiles everywhere! APCER's Holi celebration was a beautiful blend of fun and togetherness. A day filled with joy, laughter, and delicious treats! 🌸🌈  #HoliCelebration #OfficeFun #TeamSpirit #APCERcelebrates

🔬 Join APCER at #DIAEurope2025 Navigating the complex world of drug safety and regulatory compliance? Our experts are ready to guide you through:  • Evolving regulatory requirements  • Drug safety management  • Risk minimization strategies for medicinal products and medical devices 🎯 Don't miss our thought leadership session: 📋 Topic: "Benefits of Early Risk Profiling for CAR T-Cell Therapies"  🎤 Speaker: PURAV THAKKAR Vice President - Pharmacovigilance  📅 Date: March 19, 2025, Time: 3:00 – 4:30 PM CET 📍 Session: Innovation in Pharmacovigilance CAR-T, Gene Therapies and New Modalities Visit us at Booth #F5 to discover how APCER can strengthen your pharmacovigilance strategy and ensure regulatory compliance. #Pharmacovigilance #DrugSafety #RegulatoryAffairs #CARTtherapy #Innovation #LifeSciences #Healthcare #MedicalDevices Let's connect at DIA Europe 2025! 👋